Hipgnosis on 8.4% discount
Unilever has faced a tumultuous few weeks as news of its failed £50bn bid to buy GlaxoSmithKline’s consumer health unit came to light along with job cuts, scathing remarks from star fund managers and an activist investor taking a position.
PE trusts dominated in 2021
"Thrive, evolve or consolidate"
Concerns about its expense and complexity
Joins from Charles Stanley